4.6 Article

In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach

Ashish M. Kanhed et al.

Summary: COVID-19 is a worldwide pandemic caused by the novel coronavirus, requiring structural and non-structural proteins for replication mainly by the main protease (Mpro). Systematic screening of approved drug library and Asinex BioDesign library identified potential antiviral agents, with structural modifications needed for stability and safety.Screenings of the libraries resulted in molecules with promising interactions with the target protein Mpro, categorized into different classes for further drug development.

MOLECULAR DIVERSITY (2021)

Article Chemistry, Medicinal

In silicoDrug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking

Claudio N. Cavasotto et al.

Summary: The paragraph discusses the emergence of COVID-19 caused by SARS-CoV-2 in December 2019 in Wuhan, China, becoming a global pandemic by March 2020. Over 21 million cases and 750,000 deaths have been reported worldwide. It suggests the use of drug repurposing as a potentially effective strategy, presenting a docking-based screening of approved drugs and compounds for potential antiviral activity against SARS-CoV-2. Further evaluation and clinical trials are necessary to confirm the efficacy of these compounds in treating COVID-19.

MOLECULAR INFORMATICS (2021)

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Review Chemistry, Medicinal

RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

Lei Tian et al.

Summary: The RdRp enzyme, a therapeutic target for RNA virus infections, plays a crucial role in RNA synthesis. Promising RdRp inhibitors currently in studies offer potential for developing more effective anti-RNA virus drugs, which may be used for COVID-19 treatment in the current health emergency.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

Functional and druggability analysis of the SARS-CoV-2 proteome

Claudio N. Cavasotto et al.

Summary: This study focused on the binding hotspots analysis of the viral proteome of COVID-19, identifying potential druggable sites that could expand current drug discovery efforts. The hope is that these findings will aid in understanding the molecular determinants of the disease and broaden the repertoire of viral targets in the search for repurposed or novel drugs against COVID-19.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19

Divya M. Teli et al.

Summary: This study investigates the antiviral potential of various plant compounds against SARS-CoV-2, with solanine, acetoside, and rutin identified as promising dual inhibitors for both Mpro and spike glycoprotein RBD. Acetoside and curcumin were found to inhibit Mpro covalently, with curcumin showing favorable physicochemical and pharmacokinetic properties for potential development as a treatment option against COVID-19.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Multidisciplinary Sciences

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Yan Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Review Chemistry, Medicinal

The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020

Yuzhi Liu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: anin silicorepurposing study

Witor Ribeiro Ferraz et al.

FUTURE MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Drug Discovery Strategies for SARS-CoV-2

Zeenat A. Shyr et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)

Article Chemistry, Medicinal

A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2

Verena Battisti et al.

MOLECULAR INFORMATICS (2020)

Review Pharmacology & Pharmacy

A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)

Fangfang Huang et al.

PHARMACOLOGICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Druggable targets from coronaviruses for designing new antiviral drugs

Leandro Rocha Silva et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Review Chemistry, Multidisciplinary

Natural products' role against COVID-19

Ananda da Silva Antonio et al.

RSC ADVANCES (2020)

Article Biochemical Research Methods

CHARMM36m: an improved force field for folded and intrinsically disordered proteins

Jing Huang et al.

NATURE METHODS (2017)

Review Chemistry, Medicinal

Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift

Talambedu Usha et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents

Pradeep S. Jadhavar et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Chemistry, Multidisciplinary

Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations

Wenbo Yu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

Article Chemistry, Medicinal

Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites

Lewis R. Vidler et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

Review Biology

Molecular dynamics simulations and drug discovery

Jacob D. Durrant et al.

BMC BIOLOGY (2011)

Review Biochemical Research Methods

Drug discovery beyond the 'rule-of-five'

Ming-Qiang Zhang et al.

CURRENT OPINION IN BIOTECHNOLOGY (2007)

Article Biochemical Research Methods

Development of softcore potential functions for overcoming steric barriers in molecular dynamics simulations

V Hornak et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)